{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:41:20Z","timestamp":1792428080305,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"vor","delay-in-days":89,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Key Project of Science and Technology Plan of Shaoyang City","award":["2022NS3053"],"award-info":[{"award-number":["2022NS3053"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Direct"],"DOI":"10.1186\/s13062-026-00910-4","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T17:26:10Z","timestamp":1784741170000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Single-cell RNA sequencing reveals that TAF7 promotes colorectal cancer stemness by targeting SOX2"],"prefix":"10.1186","volume":"21","author":[{"given":"Xiaohui","family":"Ai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yupei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaojun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shulin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"key":"910_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"910_CR2","doi-asserted-by":"crossref","unstructured":"Huo Z, Liu G, Li J. Recent research progress and clinical status of immunotherapy for colorectal cancer. J Adv Res. 2025.","DOI":"10.1016\/j.jare.2025.06.089"},{"key":"910_CR3","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1186\/s12885-025-13777-x","volume":"25","author":"O Almilaji","year":"2025","unstructured":"Almilaji O, Sharples L, Aggarwal A, Cromwell D, Horgan K, Braun M, et al. Value of hospital administrative data linked to national cancer registry records to identify metastatic disease at time of primary diagnosis in colorectal cancer patients: a study using national data in England. BMC Cancer. 2025;25:407.","journal-title":"BMC Cancer"},{"key":"910_CR4","doi-asserted-by":"crossref","unstructured":"Zurlo IV, Calegari MA, Congedo MT, Basso M, Vita ML, Petracca Ciavarella L, et al. A retrospective analysis of real-life management of colorectal cancer lung-limited metastases treated with surgery: outcomes and prognostic factors. J Clin Med. 2024;13.","DOI":"10.3390\/jcm13226651"},{"key":"910_CR5","doi-asserted-by":"publisher","first-page":"113202","DOI":"10.18632\/oncotarget.21912","volume":"8","author":"W Wu","year":"2017","unstructured":"Wu W, Yan S, Liao X, Xiao H, Fu Z, Chen L, et al. Curative versus palliative treatments for colorectal cancer with peritoneal carcinomatosis: a systematic review and meta-analysis. Oncotarget. 2017;8:113202\u201312.","journal-title":"Oncotarget"},{"key":"910_CR6","doi-asserted-by":"publisher","first-page":"14849","DOI":"10.1007\/s00210-025-04235-3","volume":"398","author":"SI Mohammad","year":"2025","unstructured":"Mohammad SI, Vasudevan A, Nadhim Mohammed S, Uthirapathy S, M MR, Kundlas M, et al. Anti-metastatic potential of flavonoids for the treatment of cancers: focus on epithelial-mesenchymal transition (EMT) process. Naunyn Schmiedebergs Arch Pharmacol. 2025;398:14849\u201375.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"910_CR7","doi-asserted-by":"publisher","first-page":"3203","DOI":"10.1016\/j.devcel.2021.11.006","volume":"56","author":"F Luond","year":"2021","unstructured":"Luond F, Sugiyama N, Bill R, Bornes L, Hager C, Tang F, et al. Distinct contributions of partial and full EMT to breast cancer malignancy. Dev Cell. 2021;56:3203\u2013e2111.","journal-title":"Dev Cell"},{"key":"910_CR8","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.stem.2024.04.004","volume":"31","author":"JJ Loh","year":"2024","unstructured":"Loh JJ, Ma S. Hallmarks of cancer stemness. Cell Stem Cell. 2024;31:617\u201339.","journal-title":"Cell Stem Cell"},{"key":"910_CR9","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.stem.2024.06.003","volume":"31","author":"PE Saw","year":"2024","unstructured":"Saw PE, Liu Q, Wong PP, Song E. Cancer stem cell mimicry for immune evasion and therapeutic resistance. Cell Stem Cell. 2024;31:1101\u201312.","journal-title":"Cell Stem Cell"},{"key":"910_CR10","doi-asserted-by":"publisher","first-page":"1513404","DOI":"10.3389\/fimmu.2025.1513404","volume":"16","author":"A Butkute","year":"2025","unstructured":"Butkute A, Baltramonaitis M, Malmige S, Darinskas A, Pasukoniene V, Mlynska A. Targeting stemness pathways modulates macrophage polarization and reprograms the tumor microenvironment. Front Immunol. 2025;16:1513404.","journal-title":"Front Immunol"},{"key":"910_CR11","doi-asserted-by":"crossref","unstructured":"Sawai K, Koneri K, Kimura Y, Goi T. CD133 expression in circulating tumor cells as a prognostic marker in colorectal cancer. Int J Mol Sci. 2025;26.","DOI":"10.20944\/preprints202504.1362.v1"},{"key":"910_CR12","doi-asserted-by":"publisher","first-page":"eabi5751","DOI":"10.1126\/sciadv.abi5751","volume":"7","author":"D Cheng","year":"2021","unstructured":"Cheng D, Semmens K, McManus E, Chen Q, Meerzaman D, Wang X, et al. The nuclear transcription factor, TAF7, is a cytoplasmic regulator of protein synthesis. Sci Adv. 2021;7:eabi5751.","journal-title":"Sci Adv"},{"key":"910_CR13","doi-asserted-by":"publisher","first-page":"e31167","DOI":"10.1002\/jcp.31167","volume":"239","author":"JP Luna-Arias","year":"2024","unstructured":"Luna-Arias JP, Castro-Munozledo F. Participation of the TBP-associated factors (TAFs) in cell differentiation. J Cell Physiol. 2024;239:e31167.","journal-title":"J Cell Physiol"},{"key":"910_CR14","doi-asserted-by":"publisher","first-page":"111989","DOI":"10.1016\/j.isci.2025.111989","volume":"28","author":"W Zhang","year":"2025","unstructured":"Zhang W, Wang J, Li H, Zhang X, Yao D, Zhang H, et al. TAF7 directly targets SAA1 to enhance triple-negative breast cancer metastasis via phosphorylating E-cadherin and N-cadherin. iScience. 2025;28:111989.","journal-title":"iScience"},{"key":"910_CR15","doi-asserted-by":"crossref","unstructured":"Kim M, Bakyt L, Akhmetkaliyev A, Toktarkhanova D, Bulanin D. Re-sensitizing cancer stem cells to conventional chemotherapy agents. Int J Mol Sci. 2023;24.","DOI":"10.3390\/ijms24032122"},{"key":"910_CR16","doi-asserted-by":"crossref","unstructured":"Hernandez-Lopez R, Torrens-Mas M, Pons DG, Company MM, Falco E, Fernandez T, et al. Mitochondrial function differences between tumor tissue of human metastatic and premetastatic CRC. Biology (Basel). 2022;11.","DOI":"10.3390\/biology11020293"},{"key":"910_CR17","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13045-025-01684-4","volume":"18","author":"T Shang","year":"2025","unstructured":"Shang T, Jia Z, Li J, Cao H, Xu H, Cong L, et al. Unraveling the triad of hypoxia, cancer cell stemness, and drug resistance. J Hematol Oncol. 2025;18:32.","journal-title":"J Hematol Oncol"},{"key":"910_CR18","doi-asserted-by":"publisher","first-page":"217917","DOI":"10.1016\/j.canlet.2025.217917","volume":"631","author":"J He","year":"2025","unstructured":"He J, Li W, Wang S, Lan J, Hong X, Liao L, et al. Cancer associated fibroblasts-derived lactate induces oxaliplatin treatment resistance by promoting cancer stemness via ANTXR1 lactylation in colorectal cancer. Cancer Lett. 2025;631:217917.","journal-title":"Cancer Lett"},{"key":"910_CR19","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.semcancer.2022.12.010","volume":"88","author":"A Chaudhary","year":"2023","unstructured":"Chaudhary A, Raza SS, Haque R. Transcriptional factors targeting in cancer stem cells for tumor modulation. Semin Cancer Biol. 2023;88:123\u201337.","journal-title":"Semin Cancer Biol"},{"key":"910_CR20","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.lungcan.2020.06.035","volume":"147","author":"Y Kidokoro","year":"2020","unstructured":"Kidokoro Y, Sakabe T, Haruki T, Kadonaga T, Nosaka K, Nakamura H, et al. Gene expression profiling by targeted RNA sequencing in pathological stage I lung adenocarcinoma with a solid component. Lung Cancer. 2020;147:56\u201363.","journal-title":"Lung Cancer"},{"key":"910_CR21","first-page":"101036","volume":"20","author":"M Mazloomi","year":"2025","unstructured":"Mazloomi M, Doustmihan A, Alimohammadvand S, Hamishehkar H, Hamblin MR, Jahanban Esfahlan R. Advanced drug delivery platforms target cancer stem cells. Asian J Pharm Sci. 2025;20:101036.","journal-title":"Asian J Pharm Sci"},{"key":"910_CR22","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/s41568-021-00332-6","volume":"21","author":"AW Lambert","year":"2021","unstructured":"Lambert AW, Weinberg RA. Linking EMT programmes to normal and neoplastic epithelial stem cells. Nat Rev Cancer. 2021;21:325\u201338.","journal-title":"Nat Rev Cancer"},{"key":"910_CR23","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s13046-020-01690-z","volume":"39","author":"Q Tang","year":"2020","unstructured":"Tang Q, Chen J, Di Z, Yuan W, Zhou Z, Liu Z, et al. TM4SF1 promotes EMT and cancer stemness via the Wnt\/beta-catenin\/SOX2 pathway in colorectal cancer. J Exp Clin Cancer Res. 2020;39:232.","journal-title":"J Exp Clin Cancer Res"},{"key":"910_CR24","doi-asserted-by":"publisher","first-page":"114807","DOI":"10.1016\/j.celrep.2024.114807","volume":"43","author":"T Schaefer","year":"2024","unstructured":"Schaefer T, Mittal N, Wang H, Ataman M, Candido S, Lotscher J, et al. Nuclear and cytosolic fractions of SOX2 synergize as transcriptional and translational co-regulators of cell fate. Cell Rep. 2024;43:114807.","journal-title":"Cell Rep"},{"key":"910_CR25","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1111\/cas.15653","volume":"114","author":"S Liang","year":"2023","unstructured":"Liang S, Wang Q, Wen Y, Wang Y, Li M, Wang Q, et al. Ligand-independent EphA2 contributes to chemoresistance in small-cell lung cancer by enhancing PRMT1-mediated SOX2 methylation. Cancer Sci. 2023;114:921\u201336.","journal-title":"Cancer Sci"},{"key":"910_CR26","doi-asserted-by":"publisher","first-page":"524","DOI":"10.7150\/ijbs.102381","volume":"21","author":"F Zu","year":"2025","unstructured":"Zu F, Chen C, Geng Q, Li H, Chan B, Luo G, et al. Smad2 Cooperating with TGIF2 Contributes to EMT and Cancer Stem Cells Properties in Pancreatic Cancer via Co-Targeting SOX2. Int J Biol Sci. 2025;21:524\u201343.","journal-title":"Int J Biol Sci"},{"key":"910_CR27","doi-asserted-by":"publisher","first-page":"155386","DOI":"10.1016\/j.prp.2024.155386","volume":"260","author":"K Hushmandi","year":"2024","unstructured":"Hushmandi K, Saadat SH, Mirilavasani S, Daneshi S, Aref AR, Nabavi N, et al. The multifaceted role of SOX2 in breast and lung cancer dynamics. Pathol Res Pract. 2024;260:155386.","journal-title":"Pathol Res Pract"},{"key":"910_CR28","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/s41419-021-03733-5","volume":"12","author":"Y Zhu","year":"2021","unstructured":"Zhu Y, Huang S, Chen S, Chen J, Wang Z, Wang Y, et al. SOX2 promotes chemoresistance, cancer stem cells properties, and epithelial-mesenchymal transition by beta-catenin and Beclin1\/autophagy signaling in colorectal cancer. Cell Death Dis. 2021;12:449.","journal-title":"Cell Death Dis"},{"key":"910_CR29","doi-asserted-by":"crossref","unstructured":"Feng Y, Zhu N, Bedi K, Li J, Perera C, Green M, et al. SOX9 suppresses colon cancer via inhibiting epithelial-mesenchymal transition and SOX2 induction. J Clin Invest. 2025;135.","DOI":"10.1172\/JCI184115"},{"key":"910_CR30","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1186\/s12967-023-04120-8","volume":"21","author":"Z Li","year":"2023","unstructured":"Li Z, Yang Z, Liu W, Zhu W, Yin L, Han Z, et al. Disheveled3 enhanced EMT and cancer stem-like cells properties via Wnt\/beta-catenin\/c-Myc\/SOX2 pathway in colorectal cancer. J Transl Med. 2023;21:302.","journal-title":"J Transl Med"},{"key":"910_CR31","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13578-024-01213-9","volume":"14","author":"C Luo","year":"2024","unstructured":"Luo C, Yu Y, Zhu J, Chen L, Li D, Peng X, et al. Deubiquitinase PSMD7 facilitates pancreatic cancer progression through activating Nocth1 pathway via modifying SOX2 degradation. Cell Biosci. 2024;14:35.","journal-title":"Cell Biosci"},{"key":"910_CR32","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s10142-018-0641-9","volume":"19","author":"Y Tian","year":"2019","unstructured":"Tian Y, Xu Y, Wang H, Shu R, Sun L, Zeng Y, et al. Comprehensive analysis of microarray expression profiles of circRNAs and lncRNAs with associated co-expression networks in human colorectal cancer. Funct Integr Genomics. 2019;19:311\u201327.","journal-title":"Funct Integr Genomics"},{"key":"910_CR33","doi-asserted-by":"publisher","first-page":"15360","DOI":"10.1002\/jcb.28803","volume":"120","author":"S Hao","year":"2019","unstructured":"Hao S, Tian W, Chen Y, Wang L, Jiang Y, Gao B, et al. MicroRNA-374c-5p inhibits the development of breast cancer through TATA-box binding protein associated factor 7-mediated transcriptional regulation of DEP domain containing 1. J Cell Biochem. 2019;120:15360\u20138.","journal-title":"J Cell Biochem"},{"key":"910_CR34","doi-asserted-by":"publisher","first-page":"3008","DOI":"10.7150\/ijbs.93201","volume":"20","author":"J Zhang","year":"2024","unstructured":"Zhang J, Duan B, Li F, Jing X, Li R, Cai S, et al. SETD7 Promotes Cell Proliferation and Migration via Methylation-mediated TAF7 in Clear Cell Renal Cell Carcinoma. Int J Biol Sci. 2024;20:3008\u201327.","journal-title":"Int J Biol Sci"}],"container-title":["Biology Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13062-026-00910-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-026-00910-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-026-00910-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:03:19Z","timestamp":1792425799000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13062-026-00910-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["910"],"URL":"https:\/\/doi.org\/10.1186\/s13062-026-00910-4","relation":{},"ISSN":["1745-6150"],"issn-type":[{"value":"1745-6150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"assertion":[{"value":"3 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experiments were approved by the Zhejiang Luoxi Medical Technology Co., Ltd., Hangzhou, China (Approval No.: LX4825031001), strictly adhering to the Animal Management Regulations and the NIH Guide for the Care and Use of Laboratory Animals.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"210"}}